share_log

Is China Reform Health Management and Services Group (SZSE:000503) Using Debt In A Risky Way?

Is China Reform Health Management and Services Group (SZSE:000503) Using Debt In A Risky Way?

国新健康(SZSE:000503)是否在冒险地使用债务?
Simply Wall St ·  2024/10/25 20:45

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know worries about.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. As with many other companies China Reform Health Management and Services Group Co., Ltd. (SZSE:000503) makes use of debt. But the more important question is: how much risk is that debt creating?

霍华德·马克斯用一个很好的说法来形容,他说,与其担心股价波动,'永久损失的可能性才是我担心的风险……我认识的每个实际投资者都在担心这个问题。'所以很明显,当你考虑任何特定股票的风险时,你需要考虑债务,因为过多的债务可能会拖垮一家公司。与许多其他公司一样,国新健康管理服务集团股份有限公司(SZSE:000503)利用债务。但更重要的问题是:这笔债务到底造成了多大风险?

When Is Debt Dangerous?

债务何时有危险?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. If things get really bad, the lenders can take control of the business. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we examine debt levels, we first consider both cash and debt levels, together.

一般来说,只有当一家公司无法轻松偿还债务时,债务才会变成真正的问题,无论是通过筹集资本还是通过自己的现金流。如果情况变得非常糟糕,债权人可以控制企业。虽然这种情况并不常见,但我们经常看到负债累累的公司因为债权人迫使他们以困境价格发行股票而永久稀释股东。然而,通过取代稀释,债务可以成为需要资本以高回报率投资增长的企业的一个非常好的工具。当我们审查负债水平时,我们首先考虑现金和债务水平。

What Is China Reform Health Management and Services Group's Net Debt?

中国改革健康管理服务集团的净债务是多少?

You can click the graphic below for the historical numbers, but it shows that as of June 2024 China Reform Health Management and Services Group had CN¥265.3m of debt, an increase on CN¥130.1m, over one year. However, it does have CN¥1.30b in cash offsetting this, leading to net cash of CN¥1.03b.

您可以点击下方的图表查看历史数据,但它显示,截至2024年6月,国新健康管理服务集团的债务为26530万人民币,比一年前的13010万人民币增加。然而,其有13亿人民币的现金抵消了这笔债务,导致净现金达到10.3亿人民币。

big
SZSE:000503 Debt to Equity History October 26th 2024
SZSE:000503债务与股本历史数据2024年10月26日

How Healthy Is China Reform Health Management and Services Group's Balance Sheet?

中国改革健康管理与服务集团的资产负债表健康状况如何?

According to the last reported balance sheet, China Reform Health Management and Services Group had liabilities of CN¥575.0m due within 12 months, and liabilities of CN¥1.17m due beyond 12 months. On the other hand, it had cash of CN¥1.30b and CN¥235.7m worth of receivables due within a year. So it actually has CN¥958.8m more liquid assets than total liabilities.

根据最近披露的资产负债表,中国改革健康管理与服务集团有长期到期的人民币57500万的负债,以及超过12个月到期的117万人民币的负债。另一方面,该公司拥有13亿人民币的现金和一年内到期的23570万人民币的应收账款。因此,实际上,其流动资产比总负债多95880万人民币。

This short term liquidity is a sign that China Reform Health Management and Services Group could probably pay off its debt with ease, as its balance sheet is far from stretched. Simply put, the fact that China Reform Health Management and Services Group has more cash than debt is arguably a good indication that it can manage its debt safely. There's no doubt that we learn most about debt from the balance sheet. But it is China Reform Health Management and Services Group's earnings that will influence how the balance sheet holds up in the future. So if you're keen to discover more about its earnings, it might be worth checking out this graph of its long term earnings trend.

这种短期流动性表明中国改革健康管理与服务集团可能可以轻松偿还债务,因为其资产负债表并不紧张。简而言之,中国改革健康管理与服务集团拥有的现金超过债务的事实,可以说是它可以安全管理债务的一个良好指标。毫无疑问,我们大多数关于债务的了解都来自资产负债表。但中国改革健康管理与服务集团的收入将影响资产负债表在未来的情况。因此,如果您希望了解更多关于其收入的信息,值得查看其长期收入趋势图表。

Over 12 months, China Reform Health Management and Services Group reported revenue of CN¥367m, which is a gain of 12%, although it did not report any earnings before interest and tax. We usually like to see faster growth from unprofitable companies, but each to their own.

在过去12个月中,中国改革健康管理与服务集团的营业收入为36700万人民币,增长了12%,尽管未报告任何利息和税前收入。我们通常希望看到不盈利公司的增长更快,但各有所好。

So How Risky Is China Reform Health Management and Services Group?

那么中国改革健康管理与服务集团的风险有多大?

By their very nature companies that are losing money are more risky than those with a long history of profitability. And we do note that China Reform Health Management and Services Group had an earnings before interest and tax (EBIT) loss, over the last year. And over the same period it saw negative free cash outflow of CN¥161m and booked a CN¥68m accounting loss. But the saving grace is the CN¥1.03b on the balance sheet. That means it could keep spending at its current rate for more than two years. Overall, its balance sheet doesn't seem overly risky, at the moment, but we're always cautious until we see the positive free cash flow. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. To that end, you should be aware of the 1 warning sign we've spotted with China Reform Health Management and Services Group .

从本质上讲,亏损的公司比具有长期盈利历史的公司更具风险性。我们注意到,过去一年中,中国改革健康管理与服务集团的利息和税前收入(EBIT)亏损。同期,其负的自由现金流为16100万人民币,并计提了6800万人民币的会计损失。但拯救之处在于资产负债表上的10.3亿人民币。这意味着它可以按照当前速度继续支出两年以上。总体而言,目前来看,其资产负债表似乎并不过于冒险,但在看到正面的自由现金流之前,我们始终保持谨慎。在分析债务水平时,资产负债表是显而易见的起点。但最终,每家公司都可能存在超出资产负债表范围的风险。因此,您应该注意我们发现的中国改革健康管理与服务集团的1个警示信号。

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

如果您有兴趣投资能够在不负债的情况下增长利润的企业,请查看这份免费列表,其中列出了在资产负债表上拥有净现金的成长型企业。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发